The House has passed a revised version of the Medical Marijuana and Cannabidiol Research Expansion Act, HR 8454, sending it back to the Senate for action. With previous bipartisanContinue Reading A Green Light for Canna-Research? Medical Marijuana and CBD Research Bill on the Cusp
Jae is an associate in the FDA Regulatory Group, focusing on regulatory, transactional, and litigation matters impacting clients in the life sciences and consumer products industries. Her broad regulatory practice encompasses a wide range of products, including medical devices, drugs, dietary supplements, foods and beverages, alcohol, and cosmetics. She also has experience defending large multinational companies in product liability, false advertising, and commercial litigation.
At the federal level, multiple agencies have oversight over the marketing, sale, distribution, and transportation of hemp-derived CBD products. The chart below offers a high-level summary of these federal…
Continue Reading Federal Agencies’ Current Positions on Hemp-Derived CBD Products
The US Hemp Production Handbook offers a high-level, concise overview of the basic rules and regulations for producing hemp in the United States.
Continue Reading The US Hemp Production Handbook